CD4 and neoplasm: Interestingly, lower KMO mRNA expression was seen in CD4+ T-cells upon co-culture with MCLs (Fig. 5d), suggesting that KMO may play a role in determining the levels of KYNA and may also be an exciting candidate regulating the kynurenine pathway in tumour immunity (Fig. 5e).